Share on LinkedInShare on LinkedIn

ARTICLE · 27 MAY 2025

A Conversation With Tamer Mohamed (Video)

Hello everybody. I'm Justin Young. I'm a partner in Osler's Emerging and High Growth Companies Group, and I'm a contributor to the Deal Points Report.

CanadaCorporate/Commercial Law

Justin Young: Hello everybody. I'm Justin Young. I'm a partner in Osler's Emerging and High Growth Companies Group, and I'm a contributor to the Deal Points Report. Today I'm really pleased to welcome Tamer Mohamed to the conversation. Tamer is a bioengineer, inventor and entrepreneur. Tamer co-founded and serves as CEO of Aspect Biosystems. Under his leadership Aspect is grown to over a hundred people, secured more than 260 million in funding and established partnerships with industry leaders like Novo Nordisk, a recognized visionary in regenerative medicine. He's spoken at global events including TEDx Bloomberg New Economy Forum and the JP Morgan Healthcare Conference. He has been named a Bloomberg New Economy Catalyst, one of the top 50 healthcare technology CEOs and an EY Entrepreneur of the Year. Tamer also serves on the boards of BIOTECanada and Stem Cell Network helping shape the future of biotech in Canada. Tamer, welcome to the conversation.

We operate a free-to-view policy, asking only that you register in order to read all of our content. Please login or register to view the rest of this article.

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

See more popular content from